Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):151–61.
Kijima A, Murota H, Takahashi A, et al. Prevalence and impact of past history of food allergy in atopic dermatitis. Allergol Int. 2013;62:105–12.
Lammintausta K, Kalimo K, Raitala R, et al. Prognosis of atopic dermatitis. A prospective study in early adulthood. Int J Dermatol. 1991;30:563–8.
Morren MA, Przybilla B, Bamelis M, et al. Atopic dermatitis: triggering factors. J Am Acad Dermatol. 1994;31:467–73.
Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med. 2007;70:102–16.
Kijima A, Murota H, Matsui S, et al. Abnormal axon reflex-mediated sweating correlates with high state of anxiety in atopic dermatitis. Allergol Int. 2012;61:469–73.
Higaki Y, Kawamoto K, Kamo T, et al. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol. 2002;29:693–8.
Shirata K, Nishitani Y, Fujino Y, et al. The importance of mental support to the patients with adult atopic dermatitis. Osaka City Med J. 1996;42:45–52.
Hashizume H, Horibe T, Ohshima A, et al. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol. 2005;152:1161–4.
Ando T, Hashiro M, Noda K, et al. Development and validation of the psychosomatic scale for atopic dermatitis in adults. J Dermatol. 2006;33:439–50.
Turkoglu O, Mutlu HH. Evaluation of stress scores throughout radiological biopsies. Iran J Radiol. 2016;13:e37978.
Santos MA, Nakano TC, Mendes FA, et al. Emotional stress evaluation of patients with moderate and severe sleep apnea syndrome. Int Arch Otorhinolarygol. 2017;21:28–32.
Kuhlmann SM, Huss M, Burger A, et al. Coping with stress in medical students: results of a randomized controlled trial using a mindfulness-based stress prevention training (MediMind) in Germany. BMC Med Educ. 2016;16:316.
Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4:92–100.
Faulstich ME, Willamson DA. An overview of atopic dermatitis: toward a bio-behavioural integration. J Psychosom Res. 1985;29:647–54.
Aioi A, Okuda M, Matsui M, et al. Effect of high population density environment on skin barrier function in mice. J Dermatol Sci. 2001;25:189–97.
Garg A, Chren MM, Sands LP, et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-assiciated skin disorders. Arch Dermatol. 2001;137:53–9.
Arck PC, Slominski A, Theoharides TC, et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol. 2006;126:1697–704.
Tausk F, Elenkov I, Moynihan J. Psychoneuroimmunology. Dermatol Ther. 2008;21:22–31.
Elnekov IJ. Glicocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci. 2004;1024:138–46.
Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5:752–60.
Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411–7.
Elias PM, Sun R, Eder AR, et al. Treating atopic dermatitis at the source: corrective barrier repair therapy based upon new pathogenic insights. Expert Rev Dermatol. 2013;8:27–36.
Toyoda M, Nakamura M, Makino T, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol. 2002;147:71–9.
Pavlovic S, Liezmann C, Blois SM, et al. Substance P is a key mediator of stress- induced protection from allergic sensitization via modified antigen presentation. J Immunol. 2011;186:848–55.
Fukudo S. Hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. Chapter 28, section II: neuro-gastroenterology. Wood JD Section Editor. In: Johnson L, editor. Physiology of the gastrointestinal tract. 5th ed. Oxford, UK: Elsevier; 2012. p. 795–815.
Asadi S, Alysandratos KD, Angelidou A, et al. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012;132:324–9.
Baldwin AL. Mast cell activation by stress. Methods Mol Biol. 2006;315:349–60.
Senra MS, Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br J Dematol. 2014;170:38–43.
Arck PC, Handjiski B, Kuhlmei A, et al. Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med. 2005;83:386–96.
Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological approaches to relapse prevention. J Consult Clin Psycho. 1995;63:624–35.